JPMorgan Chase & Co. Reduces Position in Axcelis Technologies, Inc. (NASDAQ:ACLS)

JPMorgan Chase & Co. decreased its holdings in Axcelis Technologies, Inc. (NASDAQ:ACLS) by 21.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 178,923 shares of the semiconductor company’s stock after selling 49,921 shares during the period. JPMorgan Chase & Co.’s holdings in Axcelis Technologies were worth $18,760,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Ashton Thomas Private Wealth LLC bought a new position in Axcelis Technologies in the 2nd quarter worth approximately $39,000. Meeder Asset Management Inc. bought a new position in shares of Axcelis Technologies in the second quarter worth $69,000. Truvestments Capital LLC purchased a new position in shares of Axcelis Technologies in the third quarter valued at $69,000. KBC Group NV raised its stake in shares of Axcelis Technologies by 30.3% during the 3rd quarter. KBC Group NV now owns 934 shares of the semiconductor company’s stock valued at $98,000 after purchasing an additional 217 shares during the period. Finally, Future Financial Wealth Managment LLC purchased a new stake in Axcelis Technologies during the 3rd quarter worth about $105,000. Institutional investors own 89.98% of the company’s stock.

Axcelis Technologies Stock Performance

Shares of ACLS opened at $73.10 on Friday. The company has a current ratio of 4.45, a quick ratio of 3.29 and a debt-to-equity ratio of 0.04. The stock has a 50-day moving average price of $75.48 and a 200-day moving average price of $100.00. The company has a market cap of $2.38 billion, a PE ratio of 10.81, a price-to-earnings-growth ratio of 2.36 and a beta of 1.53. Axcelis Technologies, Inc. has a 12-month low of $68.23 and a 12-month high of $158.61.

Analyst Upgrades and Downgrades

ACLS has been the subject of a number of recent analyst reports. Needham & Company LLC reaffirmed a “hold” rating on shares of Axcelis Technologies in a report on Friday, November 8th. Benchmark lowered shares of Axcelis Technologies from a “buy” rating to a “hold” rating in a report on Friday, November 8th. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $167.33.

About Axcelis Technologies

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.